LNTH Lantheus Holdings, Inc.
$100.15▲ +0.23%
Healthcare
Other
After hours
$100.15▲ +0.00%
Oct 27, 4:00 PM ET
Volume 761.4K
Avg Volume (10D) 1.25M
Key Metrics & Fundamentals
Market Cap
$6.54B
P/E Ratio
24.2
Div Yield
0.00%
52W Range
50.16 - 111.86
% vs 50 MA
-0.11%
% vs 200 MA
10.21%
RSI-14
50.5
MACD Histogram
+0.0400
Beta (1Y vs SPY)
0.59
Free Cash Flow
$89.87M
Gross Rev
$388.18M
Gross Profit
$241.86M
EBITDA
$131.57M
COGS
$146.33M
Operating Exp
$141.64M
Operating Income
$100.22M
EBIT
$100.22M
Pretax Income
$93.83M
Net Income
$75.03M
EPS (Diluted)
1.11
Price & Volume History
Loading chart…
Recent News
ETFs Are Net Sellers of Lantheus (LNTH) on Oct. 22
GuruFocus.com · Oct 26, 2026 7:02 AM ET
ETFs Are Selling Lantheus (LNTH) on Oct. 19
GuruFocus.com · Oct 21, 2026 7:02 AM ET
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
Zacks · Oct 20, 2026 9:00 AM ET
Update: Market Chatter: JPMorgan Leads, Jefferies Joins $4.25 Billion Financing for Lantheus Deal
MT Newswires · Oct 16, 2026 5:52 AM ET
Market Chatter: JPMorgan Leads, Jefferies Joins $4.25 Billion Financing for Lantheus Deal
MT Newswires · Oct 15, 2026 8:48 AM ET
1 Russell 2000 Stock with Exciting Potential and 2 That Underwhelm
StockStory · Oct 12, 2026 6:55 AM ET
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
StockStory · Oct 6, 2026 8:08 AM ET
GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business
The Wall Street Journal · Oct 5, 2026 8:35 AM ET
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
GlobeNewswire · Sep 30, 2026 8:30 AM ET
Lantheus Doses First Patient in Phase 2/3 Prostate Cancer Trial
MT Newswires · Sep 28, 2026 8:58 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LNTH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.